Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Effectiveness of Virtually Simulated Intervention for Patients Having Stuttering

21 septembre 2026 mis à jour par: Riphah International University

This randomized controlled trial aims to evaluate the effectiveness of a culturally appropriate virtual reality (VR)-based speech restructuring intervention for individuals with stuttering in Pakistan. The intervention consists of five VR scenarios representing common real-life communication situations, incorporating graded difficulty levels, speech restructuring techniques, relaxation exercises, interactive avatars, and realistic audiovisual elements.

Eligible participants with stuttering will be randomly allocated to an experimental group receiving the VR-based speech restructuring intervention or a control group. Participants in the experimental group will receive 16 therapy sessions using the developed VR scenarios. Assessments will be conducted at baseline, during the intervention, and after completion of the intervention to evaluate changes in stuttering severity, speech fluency, communication attitudes, associated motor behaviors, physiological factors, and sense of presence within the virtual environment.

The study will determine whether the VR-based intervention is effective in improving speech fluency and reducing the severity and associated features of stuttering compared with the control condition. The findings will provide evidence regarding the effectiveness of VR-based speech restructuring as a culturally appropriate intervention for individuals with stuttering.

Aperçu de l'étude

Statut

Pas encore de recrutement

Les conditions

Description détaillée

This study is a randomized controlled trial designed to evaluate the effectiveness of a culturally adapted virtual reality (VR)-based speech restructuring intervention for individuals with stuttering in Pakistan. The intervention has been developed to simulate everyday communication situations within a controlled, immersive, and progressively challenging virtual environment. The overall objective of the trial is to determine whether VR-based speech restructuring can improve speech fluency and reduce stuttering severity and associated behavioral, physiological, and communication-related difficulties.

The VR intervention consists of five culturally appropriate communication scenarios representing commonly encountered real-life speaking situations in the Pakistani context: lecture hall, grocery store, restaurant, telephone conversation, and job interview. The scenarios incorporate graded levels of communication difficulty and are designed to provide opportunities for participants to practice speech restructuring techniques in progressively challenging situations. The intervention includes realistic environmental sounds, interactive avatars of different ages and genders, adjustable audience size and positioning, emotional expressions, varying question types, distractors, time-limited speaking tasks, relaxation exercises, and opportunities for repeated practice of speech restructuring techniques.

The intervention will be delivered using the Oculus Quest 2 head-mounted display. A neutral adaptation environment will be used to familiarize participants with the VR equipment and virtual environment before exposure to the therapeutic scenarios. Standard operating procedures (SOPs) will be followed to ensure standardized equipment setup, participant orientation, intervention delivery, and safety throughout the study. The intervention protocol and VR scenarios were developed and refined through a structured development process, including literature review, observation of real-life communication situations, brainstorming and ideation, storyboard development, live-action role plays, conversion into immersive virtual environments, and expert review. Content validity of the developed scenarios was established through evaluation by six experts with relevant professional experience using the Content Validity Index (CVI).

Eligible participants with stuttering will be recruited according to predefined inclusion and exclusion criteria. Participants will be randomly allocated to the experimental group or control group. The experimental group will receive the VR-based speech restructuring intervention consisting of 16 therapy sessions conducted three times per week, with each session lasting approximately 25 minutes. The intervention will begin with orientation to the VR system and training in the speech restructuring techniques. Participants will then practice the techniques within the five virtual communication scenarios, with the level of difficulty progressively increased according to the intervention protocol. Later sessions will focus on integrating skills across different communication situations and facilitating the transfer of learned speech restructuring strategies to real-life communication environments.

Participants in the control group will receive the control condition specified in the study protocol. Both groups will undergo outcome assessment at predefined time points. Baseline assessment will be conducted before commencement of the intervention, followed by an interim assessment during the intervention and a post-intervention assessment after completion of the 16 sessions. The primary outcome will be the severity of stuttering. Secondary outcomes will assess speech fluency, communication attitudes and emotions, associated motor behaviors, physiological factors associated with stuttering, and participants' sense of presence within the virtual environment, where applicable.

Speech fluency and stuttering-related outcomes will be assessed using standardized and structured assessment procedures. Outcome measures will include real-time analysis of speech fluency and dysfluency index, assessment of physiological factors associated with stuttering, the Modified S Scale for communication attitudes and emotions, assessment of associated motor behaviors, and the Presence Questionnaire for evaluating participants' experience within the virtual environment.

Data will be analyzed using SPSS. Descriptive statistics will be used to summarize participant characteristics and outcome measures. Appropriate inferential statistical tests will be used to compare changes in outcome measures between the experimental and control groups and across the predefined assessment time points. Statistical significance will be determined according to the prespecified analysis plan. The results of this randomized controlled trial will provide evidence regarding the effectiveness of a culturally adapted VR-based speech restructuring intervention for individuals with stuttering and its potential application as an adjunct or alternative approach to conventional stuttering intervention.

Type d'étude

Interventionnel

Inscription (Estimé)

44

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

  • Nom: Humaira Shamim Dr. Humaira Shamim Kiyani, PhD Rehabilitation Sciences
  • Numéro de téléphone: +923005471389
  • E-mail: humaira.shamim@riphah.edu.pk

Lieux d'étude

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

13 ans à 35 ans (Enfant, Adulte)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Participants having stuttering of any level will be included.
  • Participants having any primary behaviors like blocking, prolongations, Repetitions will be included.
  • Participants exhibiting any facial grimaces, body movements or muscular tensions will be included.
  • Age range 13-35 years (35)
  • Both Genders
  • Participants having stuttering severity from mild to severe
  • Bilingual population having at-least matriculation qualification

Exclusion Criteria:

  • Participants who have other communication problems with stuttering
  • Participants who have any associated medical condition like stroke, head trauma, or any other brain injury will also be excluded
  • Participants who had psychological problems, like depression and anxiety will be excluded from study.
  • Participants who had any intellectual or cognitive disability will be excluded from study.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Virtually Simulated Intervention

Participants receive the virtually simulated intervention developed for the management of stuttering. The study will evaluate the effectiveness of this intervention on the targeted population.

A standardized, virtually simulated intervention comprising 2D video-based communication scenarios delivered using a Meta Quest 2 virtual reality headset. Participants viewed and controlled the playback of the simulated scenarios during therapy sessions according to the study protocol. Participants will receive intervention 3 days/week for 25 minutes. A total of 16 sessions will be conducted.

Comparateur actif: Fluency Shaping Techniques

Participants will receive the intervention as per described intervention protocol.

Participants in the control group will receive traditional speech intervention for stuttering without the use of virtual reality. The intervention will involve therapist-guided practice of speech restructuring techniques in clinics by using scenario-based solutions. Participants will receive intervention sessions according to the same treatment schedule and duration as the experimental group. The intervention will focus on improving speech fluency and reducing the severity of stuttering through structured practice and application of speech restructuring techniques in everyday communication situations.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Severity of Stuttering
Délai: Baseline and approximately 6 weeks (post-test, immediately after completion of the 16-session intervention)

Change from baseline in percentage of syllables stuttered will be assessed to determine changes in speech fluency following the intervention. Speech samples consisting of 200 syllables will be analyzed. The percentage of syllables stuttered will be calculated by dividing the number of syllables containing stuttering events by the total number of syllables produced and multiplying by 100. A decrease in the percentage of syllables stuttered indicates an improvement in speech fluency.

Baseline and approximately 6 weeks (post-test, immediately after completion of the 16-session intervention)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Overall Assessment of Speaker's Experience of Stuttering
Délai: Baseline and approximately 6 weeks

Change from baseline in the overall impact of stuttering will be assessed using the Overall Assessment of the Speaker's Experience of Stuttering (OASES). The OASES assesses the speaker's experience of stuttering across multiple domains, including general information about stuttering, reactions to stuttering, communication in daily situations, and quality of life. The instrument provides an overall impact score, with higher scores indicating a greater negative impact of stuttering on the individual's life. Changes in the overall impact score from baseline to post-test will be evaluated to determine the effectiveness of the intervention.

Baseline and approximately 6 weeks

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Tehreem Ijaz, PhD Scholar, Riphah International University

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

25 octobre 2026

Achèvement primaire (Estimé)

15 décembre 2026

Achèvement de l'étude (Estimé)

15 décembre 2026

Dates d'inscription aux études

Première soumission

21 septembre 2026

Première soumission répondant aux critères de contrôle qualité

21 septembre 2026

Première publication (Réel)

28 septembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

28 septembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

21 septembre 2026

Dernière vérification

1 septembre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner